G3 Pharmaceuticals starts research and development program to pursue novel galectin-3 inhibitors Sep. 19, 2017 No Comments
BioNTech enters patent licensing agreement with Cellscript for modified mRNA technology Sep. 6, 2017 No Comments
Inactivation of PERVs to eliminate cross-species viral transmission in xenotransplantation Aug. 24, 2017 No Comments
RSS